3 ms·

So, layman question: will it increase moderna's vaccine availability? Or is it about something else entirely?

• drran 6y ago
  Moderna will sue violators of their patents when they lost their primary income source.
• meepmorp 6y ago
  This is from last year, and the answer is no. The supply constraints are unrelated to IP, and always have been.